Carlsmed, Inc. (CARL) stock
CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30123% above fair value
$17.42+0.20 (+1.16%)
Close on Nov 20, 2026Market cap $475.61MP/E –Yield –
Carlsmed free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Carlsmed's free cash flow for the twelve months ending Jun 30, 2026 was -$34.58M. For fiscal 2025 it was -$29.62M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$29.62M | – |
| FY2024 | Dec 31, 2024 | -$25.65M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.48M | – |
| Q1 FY2026 | Mar 31, 2026 | -$13.09M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.39M | – |
| Q3 FY2025 | Sep 30, 2025 | -$8.62M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.37M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.24M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.26M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.63M | – |
See a number that looks wrong?